Oorsprong van het eerstegraads netwerk van David Luo
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David Luo via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Human Resources Officer | |
| University of California, Los Angeles | College/University | Undergraduate Degree Masters Business Admin | |
| Case Western Reserve University School of Medicine | College/University | Doctorate Degree | |
Onc.ai, Inc.
 Onc.ai, Inc. Packaged SoftwareTechnology Services Onc.ai, Inc. is a digital health company that is privately held and is developing a precision oncology care management platform. The company is based in San Carlos, CA. The company aims to transform clinical decision making and is backed by premier investment firms such as the Blue Venture Fund, MassMutual Alternative Investments, and Accomplice, among others. The company is building a pipeline of physician-centered products to fulfill the potential of precision oncology. The company was founded by Akshay Nanduri, who has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Harvard Medical School | College/University | Doctorate Degree | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| IGM BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | General Counsel | |
| Haverford College | College/University | Undergraduate Degree | |
| Roche (China) Co. Ltd. | Corporate Officer/Principal | ||
| New York University School of Law | College/University | Graduate Degree | |
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Investment Managers | Consultant / Advisor | |
| University of California, Santa Barbara | College/University | Undergraduate Degree | |
| Tulane University (Louisiana) | College/University | Doctorate Degree | |
| University of Sunderland | College/University | Undergraduate Degree | |
| University of Kansas | College/University | Doctorate Degree | |
Duke Capital Partners LLC
 Duke Capital Partners LLC Investment ManagersFinance Duke Capital Partners, LLC provides financial advisory, investment, and equity services. The company was founded in 2000, and is headquartered in Charlotte, NC. | Investment Managers | Corporate Officer/Principal | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Stealth Startup Solutions LLC
 Stealth Startup Solutions LLC Miscellaneous Commercial ServicesCommercial Services Stealth Startup Solutions LLC engages in provision of consulting services. The company is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder | |
| Stanford School of Medicine | College/University | Consultant / Advisor | |
Xilis, Inc.
 Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Medical Specialties | Director of Finance/CFO | |
| GUARDANT HEALTH, INC. | Medical/Nursing Services | Private Equity Investor | |
| ANNEXON, INC. | Pharmaceuticals: Major | Private Equity Investor | |
| AMBRX INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Scient'x SA
 Scient'x SA Medical SpecialtiesHealth Technology Scient'X SA designs, develops and markets spinal implant devices for the lumbar, thoracic and cervical spine. The firm's products are designed to provide stabilization and correction to the spine for patients with degenerative disease, tumors, scoliosis, and injuries from trauma. The company was founded by Albert Alby in 1988 and is headquartered in Voisins le Bretonneux, France. | Medical Specialties | Chief Executive Officer | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| C4 THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Weill Cornell Medical College | College/University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 41 |
| Verenigd Koninkrijk | 3 |
| Nieuw-Zeeland | 2 |
| China | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 15 |
| Commercial Services | 6 |
| Finance | 4 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 28 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 12 |
| Undergraduate Degree | 8 |
| Chief Executive Officer | 7 |
Sterkste connecties
| Insiders | |
|---|---|
| Bihua Chen | 32 |
| Julie Hambleton | 15 |
| Michael Varney | 13 |
| Gary Yeung | 13 |
| Ebun Garner | 11 |
| Wei Lin | 8 |
| Lisa Tesvich-Bonora | 6 |
| Nik Chetwyn | 5 |
